News Daily News New Roles for Anticoagulation Clinics in an Era of Non-Warfarin Options Todd Neale March 01, 2016
News Conference News ISC 2016 To Anticoagulate or Not? Debating Secondary Stroke Prevention in an A-fib Patient With Microbleeds Michael O'Riordan February 23, 2016
News Daily News ROCKET AF Investigators: Problems With Warfarin Monitoring Device Did Not Skew Results Todd Neale February 04, 2016
News Daily News Investigadores del ROCKET AF: Los Problemas con un Dispositivo para la Monitorización de la Warfarina No Sesgaron los Resultados Todd Neale February 04, 2016
News Daily News Path to Top FDA Post Gets a Bit Rockier for Califf Michael O'Riordan December 09, 2015
News Industry News Real-World Data Confirms Safety and Efficacy Profile of XARELTO®, With Shorter Hospital Stays, for the Treatment of Deep Vein Thrombosis December 07, 2015
News Daily News First NOAC Antidote, Idarucizumab, Approved; Likely Won’t Hold Up Interventions Todd Neale October 26, 2015
News Daily News Aprobado el Idarucizumab, Primer Antídoto de NOAC; El Deseo es no Demorar las Intervenciones Todd Neale October 26, 2015
News Daily News Real-World Studies Highlight GI Bleeding Concerns With Newer Anticoagulants L.A. McKeown May 04, 2015
News Daily News Estudios del Mundo Exponen que Preocupan las Hemorragias Gastrointestinales secundarias a los Nuevos Anticoagulantes L.A. McKeown May 04, 2015
News Daily News ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy April 29, 2015
News Daily News ISAR-TRIPLE Publicado: No hay Beneficio Neto durante 6 Semanas frente a 6 Meses a Tratamiento Triple April 29, 2015
News Daily News La IC Empeora los Resultados Post-SCA No observándose Beneficio alguno con Apixaban Todd Neale January 28, 2015
News Daily News HF Worsens Outcomes Following ACS, With No Benefit From Apixaban Todd Neale January 28, 2015